1. «Здравоохранение Узбекистана», Статистический сборник. Государственный комитет Республики Узбекистан по статистике. Ташкент 2015 г.

2. http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001547 (Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010)

3. https://www.washingtonpost.com/news/worldviews/wp/2013/11/07/a-stunning-map-of-depressionrates-around-the-world/?utm_term=.1caf7d2d77b6 (A stunning map of depression rates around the world)

4. Государственный Реестр лекарственных средств и медицинских изделий Республики Узбекистан. – за 2006-2016 гг.

5. Priest R. G., Baldwin D. S. Depression and anxiety. — London: Martin Dunitz, 1994. — 82 с.

6. http://www.rmj.ru/articles/obshchie-stati/Klinicheskoe_primenenie_sovremennyh_antidepressantov/ (Клиническое применение современных антидепрессантов).

7. https://www.jnj.com/media-center/press-releases/esketamine-recieves-breakthrough-therapydesignation-from-us-food-and-drug-administration-for-major-depressive-disorder-with-imminent-risk-ofsuicide (Esketamine Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Major Depressive Disorder with Imminent Risk for Suicide)